Globus Medical Sees FY23 EPS $2.30 Vs $2.34 Est.; Revenue $1.125B Vs $1.12B Est.
Portfolio Pulse from Happy Mohamed
Globus Medical has increased its full year 2023 net sales guidance to $1.125 billion, up from $1.100 billion, and reaffirmed non-GAAP diluted earnings per share of $2.30. This is slightly below the estimated EPS of $2.34.
August 04, 2023 | 2:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Globus Medical's raised sales guidance for 2023 and reaffirmed EPS may have a positive impact on its stock price, despite the EPS being slightly below estimates.
Globus Medical's raised sales guidance indicates expected growth, which is a positive signal to investors. The reaffirmed EPS, despite being slightly below estimates, shows the company's confidence in its profitability. These factors may lead to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100